Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of Fufang Zanghuixiang enteric soft capsules for functional dyspepsia (epigastric pain syndrome)
CTR20211727Phase 3Terminated
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Jan 2022
- Countries
- 1
01
Overview
A Phase 3 trial of Fufang Zanghuixiang enteric soft capsule in functional dyspepsia (FD), sponsored by Tianjin Institute of Pharmaceutical Research. Started Jan 2022; status: terminated.
02
Drugs
Fufang Zanghuixiang enteric soft capsule
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on CTR20211727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211727.